IPO - Protagenic Therapeutics, Inc.\new

Form Type: CORRESP

Filing Date: 2024-12-23

Corporate Action: Ipo

Type: New

Accession Number: 000149315224051813

Filing Summary: Protagenic Therapeutics, Inc. filed a request with the SEC to declare its Registration Statement on Form S-1 effective on December 26, 2024. The Registration Statement was initially filed on December 20, 2024, under File No. 333-283949. The request indicates the company's intention to proceed with its initial public offering.

Document Link: View Document